Q2 2016 13F Holders as of 6/30/2016
-
Type / Class
-
Equity / COM
-
Number of holders
-
191
-
Total shares
-
65.3M
-
Shares change
-
+14.7K
-
Total reported value, excl. options
-
$1.88B
-
Value change
-
-$6.23M
-
Put/Call ratio
-
0.07
-
Number of buys
-
117
-
Number of sells
-
-72
-
Price
-
$28.82
Significant Holders of IMPAX LABORATORIES INC - COM (IPXL) as of Q2 2016
197 filings reported holding IPXL - IMPAX LABORATORIES INC - COM as of Q2 2016.
IMPAX LABORATORIES INC - COM (IPXL) has 191 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 65.3M shares
.
Largest 10 shareholders include Hound Partners, LLC (6.76M shares), ORBIMED ADVISORS LLC (5.89M shares), BlackRock Fund Advisors (5.8M shares), VANGUARD GROUP INC (5.61M shares), Invesco Ltd. (3.4M shares), FRANKLIN RESOURCES INC (2.48M shares), ARAVT GLOBAL LLC (2.23M shares), Pennant Capital Management, LLC (1.95M shares), STATE STREET CORP (1.76M shares), and BlackRock Institutional Trust Company, N.A. (1.73M shares).
This table shows the top 191 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.